- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (409)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (2)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3982)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2023 (publication date) through May 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ren LL, Mao T, Meng P, Zhang L, Wei HY, Tian ZB. Glutamine addiction and therapeutic strategies in pancreatic cancer. World J Gastrointest Oncol 2023; 15(11): 1852-1863 [PMID: 38077649 DOI: 10.4251/wjgo.v15.i11.1852] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i11/1852.htm |
| Number | Citing Articles |
| 1 |
Sridevi Mardham, Soumya Dakshinamurthy. Immune Therapy for Pancreatic and Colon Cancers. 2025; : 325 doi: 10.1016/B978-0-443-24742-2.00001-0
|
| 2 |
Dong-Hwan Kim, Dong Joon Kim, Seong-Jun Park, Won-Jun Jang, Chul-Ho Jeong. Inhibition of GLS1 and ASCT2 Synergistically Enhances the Anticancer Effects in Pancreatic Cancer Cells. Journal of Microbiology and Biotechnology 2025; 35 doi: 10.4014/jmb.2412.12032
|
| 3 |
Fatima I. AlMaazmi, Lara J. Bou Malhab, Leen ElDohaji, Maha Saber-Ayad. Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic Strategy. Cells 2025; 14(8): 598 doi: 10.3390/cells14080598
|